[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356158-105":59,"doc-detail-356158-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","biology-aligned-cervical-cancer-screening-target-centric-biomarkers-and-next-generation-diagnostic-platforms","Biology-aligned cervical cancer screening - target-centric biomarkers and next-generation diagnostic platforms","","Cervical cancer remains a major cause of cancer-related death among women worldwide, with the highest mortality concentrated in low- and middle-income countries where screening infrastructure is limited. Although persistent high-risk human papillomavirus (hrHPV) infection drives nearly all cases through a prolonged preinvasive window, current screening methods face biological and operational constraints. Cytology has moderate sensitivity and subjective interpretation, while HPV DNA testing is sensitive but lacks specificity, shifting the burden to triage. This review proposes a target-centric framework that groups biomarkers by biological class and evaluates emerging diagnostics across HPV-derived markers, host cell-cycle regulators, non-protein biomarkers, and marker-free platforms, emphasizing point-of-care deployment, noninvasive sampling, and scalable multilayer risk stratification aligned with WHO elimination goals.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/biology-aligned-cervical-cancer-screening-target-centric-biomarkers-and-next-generation-diagnostic-platforms/356158/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/biology-aligned-cervical-cancer-screening-target-centric-biomarkers-and-next-generation-diagnostic-platforms/356158.png","ImageObject",300,407,{"name":92,"@type":93},"anakgang17","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is cervical cancer considered preventable and detectable?","Question",{"text":112,"@type":113},"Cervical cancer is driven by persistent hrHPV infection through a prolonged preinvasive window, which enables prevention and detection via vaccination and screening.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What are key limitations of current cervical cancer screening methods?",{"text":117,"@type":113},"Cytology shows moderate sensitivity with subjective interpretation; HPV DNA testing is highly sensitive but not specific for transforming infections; visual inspection offers limited reproducibility; triage and colposcopy burdens increase when specificity is lacking.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the review’s target-centric diagnostic framework improve organization of screening biomarkers?",{"text":121,"@type":113},"It organizes cervical cancer screening by the biological class of the interrogated marker rather than by the detection platform, linking each biomarker category to underlying molecular pathogenesis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356158,1790219541,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090883568,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Yu etal. Biomarker Research (2026) 14:111 Biomarker Research  \n[https://doi.org/10.1186/s40364-026-00964-6](https://doi.org/10.1186/s40364-026-00964-6)  \nREVIEW Open Access  \nBiology-aligned cervical cancer screening: target-centric biomarkers and nextgeneration diagnostic platforms  \nJin Suh Yu1,2†, Gayoung Park3†, Hyewon Seo3*, Yun Hak Kim1,4,5* and Dokyoung Kim6,7,8,9,10,11,12*  \nAbstract  \nCervical cancer remains a leading cause of cancer-related mortality among women worldwide, with mortality disproportionately concentrated in low-and middle-income countries (LMICs), where screening infrastructure is limited. Although persistent high-risk human papillomavirus (hrHPV) infection drives nearly all cervical cancers through a prolonged preinvasive window, making the disease both preventable and detectable, current screening modalities face biological and operational limitations that constrain their global impact. Cytology-based methods suffer from moderate sensitivity and subjective interpretations. HPV DNA testing is highly sensitive, it lacks specificity for transforming infections and shifts the diagnostic burden toward triage and colposcopy. Meanwhile, visual inspection methods are accessible, they offer limited reproducibility. In this review, we adopt a target-centric diagnostic framework that organizes cervical cancer screening not by detection platform but by the biological class of the marker being interrogated. We first examined the molecular pathogenesis of cervical carcinogenesis, including HPV genotype-specific biology, viral integration dynamics, oncogene-driven transformation, and epigenetic consolidation, to establish the biological rationale for each biomarker category. We then systematically evaluated conventional screening modalities and their limitations before reviewing emerging diagnostic technologies across four target domains: HPV-derived markers (DNA, mRNA, capsid proteins), host cellcycle regulators (p16INK4a, Ki-67), non-protein biomarkers (biothiols, volatile metabolites), and marker-free platforms (Raman/FT-IR spectroscopy, AI-assisted cytopathology) . Particular emphasis is placed on point-of-care (POC) deployability, noninvasive sampling strategies, and the integration of multilayered risk stratification into scalable screening pathways. By mapping diagnostic innovation onto the biological continuum of cervical carcinogenesis, this review provides a conceptual foundation for developing next-generation screening approaches that align molecular precision with global accessibility, thereby supporting progress toward the World Health Organization goal of cervical cancer elimination.  \n†Jin Suh Yu and Gayoung Park contributed equally to this work.  \n*Correspondence:  \nHyewon Seo[h.seo@kmedihub. re.kr](h.seo@kmedihub. re.kr)[ ](h.seo@kmedihub. re.kr)Yun Hak Kim [yunhak10510@pusan.ac.kr](yunhak10510@pusan.ac.kr)[ ](yunhak10510@pusan.ac.kr)Dokyoung Kim [dkim@khu.ac.kr](dkim@khu.ac.kr)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view ","cbCaiox9eGtZyni5","https://ap.wps.com/l/cbCaiox9eGtZyni5","pdf",4845461,36,"English","# Introduction\n## Burden of cervical cancer and disparities in LMICs\n## Limitations of conventional screening approaches\n# Target-centric diagnostic framework\n## Biological rationale for biomarker categories\n## Evaluation of conventional and emerging diagnostic technologies\n# Diagnostic target domains\n## HPV-derived markers\n## Host cell-cycle regulators\n## Non-protein biomarkers\n## Marker-free platforms\n# Implementation considerations\n## Point-of-care deployability\n## Noninvasive sampling and risk stratification pathways\n# Conclusion\n## Conceptual foundation for next-generation screening","[{\"question\":\"Why is cervical cancer considered preventable and detectable?\",\"answer\":\"Cervical cancer is driven by persistent hrHPV infection through a prolonged preinvasive window, which enables prevention and detection via vaccination and screening.\"},{\"question\":\"What are key limitations of current cervical cancer screening methods?\",\"answer\":\"Cytology shows moderate sensitivity with subjective interpretation; HPV DNA testing is highly sensitive but not specific for transforming infections; visual inspection offers limited reproducibility; triage and colposcopy burdens increase when specificity is lacking.\"},{\"question\":\"How does the review’s target-centric diagnostic framework improve organization of screening biomarkers?\",\"answer\":\"It organizes cervical cancer screening by the biological class of the interrogated marker rather than by the detection platform, linking each biomarker category to underlying molecular pathogenesis.\"}]","Biology-aligned cervical cancer screening - target-centric biomarkers and next-generation diagnostic platforms | PDF",1790123704,91,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bde59355731a6793c79a1eb3e1457119.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc49b19c674c7effefe1f9084bfdc085.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d2dc713a478fc0f98a9a2aba4dc16ea.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/345800ffec6cd814830f723a28d20923.webp",980,1306]